HRP20000639A2 - Quinolin-4yl derivatives i - Google Patents

Quinolin-4yl derivatives i Download PDF

Info

Publication number
HRP20000639A2
HRP20000639A2 HR20000639A HRP20000639A HRP20000639A2 HR P20000639 A2 HRP20000639 A2 HR P20000639A2 HR 20000639 A HR20000639 A HR 20000639A HR P20000639 A HRP20000639 A HR P20000639A HR P20000639 A2 HRP20000639 A2 HR P20000639A2
Authority
HR
Croatia
Prior art keywords
phenyl
quinolin
methoxy
propan
ylamino
Prior art date
Application number
HR20000639A
Other languages
English (en)
Croatian (hr)
Inventor
Alexander Alanine
Serge Burner
Bernd Buettelmann
Marie-Paule Heitz Neidhart
Georg Jaeschke
Emmanuel Pinard
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HRP20000639A2 publication Critical patent/HRP20000639A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20000639A 1999-10-01 2000-09-28 Quinolin-4yl derivatives i HRP20000639A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99119539 1999-10-01

Publications (1)

Publication Number Publication Date
HRP20000639A2 true HRP20000639A2 (en) 2001-06-30

Family

ID=8239107

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000639A HRP20000639A2 (en) 1999-10-01 2000-09-28 Quinolin-4yl derivatives i

Country Status (26)

Country Link
US (1) US6440995B1 (es)
JP (1) JP3523174B2 (es)
KR (1) KR100398561B1 (es)
CN (1) CN1181059C (es)
AR (1) AR025882A1 (es)
AT (1) ATE281436T1 (es)
AU (1) AU774363B2 (es)
BR (1) BR0004548A (es)
CA (1) CA2321324A1 (es)
CO (1) CO5200789A1 (es)
CZ (1) CZ20003575A3 (es)
DE (1) DE60015471T2 (es)
ES (1) ES2230017T3 (es)
HR (1) HRP20000639A2 (es)
HU (1) HUP0003861A3 (es)
ID (1) ID27525A (es)
IL (1) IL138777A0 (es)
MA (1) MA26752A1 (es)
NO (1) NO20004892L (es)
NZ (1) NZ507141A (es)
PE (1) PE20010648A1 (es)
PL (1) PL342876A1 (es)
PT (1) PT1088818E (es)
SG (1) SG164268A1 (es)
TR (1) TR200002831A3 (es)
ZA (1) ZA200005239B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831087B2 (en) * 2001-11-09 2004-12-14 Hoffmann-La Roche Inc. Pyridine substituted isoquinoline derivatives
WO2003068748A1 (en) * 2002-02-13 2003-08-21 F. Hoffmann-La Roche Ag Novel pyridine- and quinoline-derivatives
JP2008506695A (ja) * 2004-07-13 2008-03-06 グラクソ グループ リミテッド 抗細菌剤
WO2009042907A1 (en) * 2007-09-27 2009-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
JP6527534B2 (ja) * 2014-06-16 2019-06-05 ファンダシオン パラ ラ インベスティガシオン メディカ アプリカダFundacion Para La Investigasion Medica Aplicada ヒストンメチルトランスフェラーゼ及びdnaメチルトランスフェラーゼの二重阻害剤としての新規化合物
CN107427506A (zh) * 2014-10-14 2017-12-01 拉霍拉敏感及免疫学研究所 低分子量蛋白酪氨酸磷酸酶的抑制剂及其用途
KR20170074178A (ko) * 2015-12-21 2017-06-29 제이엔씨 주식회사 중합성 액정 화합물, 조성물, 그 액정 중합막류 및 이들의 용도
CN105646462B (zh) * 2016-01-19 2019-04-05 河南大学 芸香宁碱衍生物、其制备方法及应用
US11066420B2 (en) 2017-05-01 2021-07-20 Sanford Burnham Prebys Medical Discovery Institute Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE440008C (de) 1924-03-29 1927-05-04 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Chinolinderivaten
US4560692A (en) 1984-07-18 1985-12-24 Hoffmann-La Roche Inc. 4-Piperidino-2-phenylquinolines
GB9125515D0 (en) 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
US5441963A (en) 1991-12-20 1995-08-15 Merrell Dow Pharmaceuticals Potentiation of NMDA antagonists

Also Published As

Publication number Publication date
ID27525A (id) 2001-04-12
CN1181059C (zh) 2004-12-22
CO5200789A1 (es) 2002-09-27
AR025882A1 (es) 2002-12-18
JP2001097952A (ja) 2001-04-10
PE20010648A1 (es) 2001-06-13
NZ507141A (en) 2002-05-31
TR200002831A2 (tr) 2001-04-20
DE60015471D1 (de) 2004-12-09
US6440995B1 (en) 2002-08-27
HUP0003861A3 (en) 2002-09-30
ES2230017T3 (es) 2005-05-01
CN1290698A (zh) 2001-04-11
AU6132400A (en) 2001-04-05
BR0004548A (pt) 2001-05-29
DE60015471T2 (de) 2005-10-27
PT1088818E (pt) 2005-03-31
NO20004892D0 (no) 2000-09-29
HU0003861D0 (en) 2000-12-28
MA26752A1 (fr) 2004-12-20
JP3523174B2 (ja) 2004-04-26
TR200002831A3 (tr) 2001-04-20
SG164268A1 (en) 2010-09-29
ATE281436T1 (de) 2004-11-15
ZA200005239B (en) 2001-04-16
NO20004892L (no) 2001-04-02
CA2321324A1 (en) 2001-04-01
PL342876A1 (en) 2001-04-09
KR20010050738A (ko) 2001-06-15
AU774363B2 (en) 2004-06-24
CZ20003575A3 (cs) 2001-11-14
KR100398561B1 (ko) 2003-09-19
HUP0003861A2 (hu) 2001-10-28
IL138777A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
CN100475796C (zh) 作为大麻素受体调制剂的噻唑衍生物
Oshiro et al. 3, 4-Dihydro-2 (1 H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-3, 4-dihydro-5-methoxy-2 (1 H)-quinolinone and its derivatives
JP6126233B2 (ja) 新たなキノリン類の化合物及びその使用
CA2400657A1 (en) Derivatives of quinoline as alpha-2 antagonists
MXPA94009601A (es) Compuestos de aril y heteroaril quinazolina que inhiben tirozina cinasa del receptor del factor de estimulacion de colonias-1.
BR112012003741B1 (pt) Derivados de cromona, um processo para seu preparo e suas aplicacoes terapêuticas
JPS59219260A (ja) 新規なナフタレン−およびアザナフタレン−カルボキサミド誘導体、それを含有する製薬学的組成物、並びにそれらの製造法
JP5719852B2 (ja) 7−クロロ−キノリン−4−アミン化合物、ならびにアミロイド斑の形成を含み、及び/又はappの代謝機能障害が生じる疾患の予防又は治療のためのそれらの使用
CN108558831A (zh) 取代吡咯-4-烷基胺类化合物及其用途
HRP20000639A2 (en) Quinolin-4yl derivatives i
Höglund et al. Structure− activity relationship of quinoline derivatives as potent and selective α2c-adrenoceptor antagonists
UA100192C2 (en) 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
EP1088818B1 (en) Quinolin-4-yl derivatives
HRP20000652A2 (en) Quinolin -4-yl derivatives
US9174940B2 (en) TSH receptor antagonizing tetrahydroquinoline compounds
Liu et al. A Novel Process for Antimalarial Drug Pyronaridine Tetraphosphate
US6593324B2 (en) Dervatives of quinoline as alpha-2 antagonists
MXPA00009584A (es) Derivados de quinolin-4-il
Kumar Design, Synthesis and Evaluation of Novel Multifunctional Ligands for Treatment of Alzheimer's Disease
CZ20003630A3 (cs) 4-Chinolinové deriváty
JPH06507643A (ja) Egfおよび/又はpdgf受容体チロシンキナーゼを阻害するビスモノ−および二環式アリールおよびヘテロアリール化合物

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn